University of Minnesota, College of Continuing and Professional Studies, Health Services Management, St Paul.
Children's Minnesota Research Institute, Minneapolis.
J Pediatric Infect Dis Soc. 2019 May 11;8(2):115-121. doi: 10.1093/jpids/piy003.
Hospital practice patterns vary for switching from intravenous to oral antibiotics for community-acquired pneumonia in pediatric patients, but it is unknown how these practice patterns affect hospital lengths of stay and costs.
We conducted a retrospective study of 78673 pediatric patients (aged 3 months to 17 years) hospitalized for community-acquired pneumonia. Analyses were performed with data from the Pediatric Health Information System between 2007 and 2016, including discharge data from 48 freestanding children's hospitals. Patients who received antibiotics used to treat aspiration pneumonia and patients with a complex chronic condition were excluded to focus the study on uncomplicated cases. We modeled hospital practice patterns using hospital-level averages for the last day of service on which patients received antibiotics intravenously or first day of service on which patients received antibiotics orally.
We found that a 1-day decrease in the hospital-level average last day of service on which a patient received antibiotics intravenously reduced the average length of stay by 0.58 day (95% confidence interval [CI], -0.69 to -0.47 day) and average cost by $1332 (95% CI, -$2363 to -$300). Results were similar when hospital practice patterns were modeled using the average first day of service on which a patient received antibiotics orally. These reductions in lengths of stay and costs were not associated with a difference in 30-day readmission rates.
Given the reductions in lengths of stay and costs without sacrificing patient outcomes (readmissions), antimicrobial stewardship programs could target provider education on the duration of intravenous antibiotic therapy as a way to reduce resource utilization.
在儿科患者中,从静脉用抗生素切换为口服抗生素治疗社区获得性肺炎,医院的治疗方案存在差异,但尚不清楚这些治疗方案如何影响住院时间和费用。
我们对 78673 例(年龄 3 个月至 17 岁)因社区获得性肺炎住院的儿科患者进行了回顾性研究。分析数据来自 2007 年至 2016 年的儿科健康信息系统,包括 48 家独立儿童医院的出院数据。排除接受用于治疗吸入性肺炎的抗生素和患有复杂慢性疾病的患者,以使研究集中于单纯病例。我们使用患者接受静脉用抗生素的最后一天或开始接受口服抗生素的第一天的医院水平平均值来对医院治疗方案进行建模。
我们发现,患者接受静脉用抗生素的最后一天的医院水平平均天数减少 1 天,平均住院时间减少 0.58 天(95%置信区间[CI],-0.69 至 -0.47 天),平均费用减少 1332 美元(95%CI,-2363 至 -300 美元)。当使用患者开始接受口服抗生素的第一天的医院水平平均值来建模医院治疗方案时,结果相似。这些住院时间和费用的减少与 30 天再入院率没有差异相关。
鉴于在不影响患者结局(再入院)的情况下缩短了住院时间和降低了成本,抗菌药物管理项目可以针对提供者进行静脉用抗生素治疗持续时间的教育,以减少资源利用。